- Previous close
0.0080 - Open
0.0090 - Bid 0.0080 x --
- Ask 0.0090 x --
- Day's range
0.0080 - 0.0100 - 52-week range
0.0080 - 0.0180 - Volume
7,776,500 - Avg. Volume
1,254,100 - Market cap (intra-day)
6.703M - Beta (5Y monthly) --
- PE ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings date --
- Forward dividend & yield --
- Ex-dividend date --
- 1y target est
--
Biolidics Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions. The company operates through Cancer, Infectious Diseases, and Laboratory Services segments. It provides Covid-19 PCR testing kits. The company offers ClearCell FX1 System, an automated device that separates and enriches cancer cells from blood; and antigen and antibody test kits, as well as laboratory services. It serves academic and research institutes, hospitals, and laboratories in Singapore, China, Hong Kong, Japan, the United States, and other European Union countries. The company was incorporated in 2009 and is based in Singapore.
www.biolidics.com15
Full-time employees
31 December
Fiscal year ends
Healthcare
Sector
Diagnostics & Research
Industry
Related news
View more
Performance overview: 8YY.SI
Trailing total returns as of 08/11/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: 8YY.SI
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: 8YY.SI
View moreValuation measures
Market cap
5.96M
Enterprise value
7.08M
Trailing P/E
--
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
4.64
Price/book (mrq)
--
Enterprise value/revenue
5.92
Enterprise value/EBITDA
--
Financial highlights
Profitability and income statement
Profit margin
-221.53%
Return on assets (ttm)
-110.96%
Return on equity (ttm)
--
Revenue (ttm)
1.27M
Net income avi to common (ttm)
-2.74M
Diluted EPS (ttm)
-0.0000
Balance sheet and cash flow
Total cash (mrq)
166k
Total debt/equity (mrq)
--
Levered free cash flow (ttm)
-1.68M